Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial
February 01, 2016 at 14:49 PM EST
Shares of Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) hit a new 52-week low of $4.72 on Monday and was trading lower by more than 4 ...
